BGI Genomics Co., Ltd. (SHE:300676)
China · Delayed Price · Currency is CNY 41.27
+0.58 (1.43%)
Aug 11, 2026, 3:04 PM CST
BGI Genomics Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,842 | 3,705 | 3,867 | 4,350 | 7,053 | 6,766 |
Revenue Growth | 3.35% | -4.18% | -11.10% | -38.33% | 4.24% | -19.42% |
Gross Profit Gross Profit Growth | 1,298 | 1,270 | 1,503 | 2,147 | 3,526 | 3,921 |
Operating Income Operating Income Growth | -518.48 | -594.78 | -736.64 | 112.94 | 905.27 | 1,680 |
Net Income Net Income Growth | -573.48 | -616.66 | -902.69 | 92.9 | 802.77 | 1,462 |
Earnings Per Share EPS Growth | -1.37 | -1.48 | -2.19 | 0.23 | 1.96 | 3.55 |
EPS Growth | - | - | - | -88.48% | -44.90% | -32.25% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Mainland China (Excluding Hong Kong, Macau and Taiwan) Mainland China (Excluding Hong Kong, Macau and Taiwan) Growth | 3,134 | 3,306 | 3,459 | 3,629 | 2,885 |
Europe and Africa Europe and Africa Growth | 224.64 | 224.63 | 216.81 | 388.52 | 938.75 |
Americas Americas Growth | 59.83 | 90.32 | 116.15 | 244.71 | 432.13 |
Asia (Including China, Hong Kong, Macau, and Taiwan) and Oceania Asia (Including China, Hong Kong, Macau, and Taiwan) and Oceania Growth | 286.43 | 245.94 | 557.56 | 2,791 | 2,511 |
Total Total Growth | 3,705 | 3,867 | 4,350 | 7,053 | 6,766 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 3,365 | 3,778 | 4,310 | 5,509 | 6,403 | 8,646 |
Total Debt Total Debt Growth | 603.48 | 636.85 | 471.27 | 365.4 | 200.01 | 847.75 |
Net Cash (Debt) Net Cash Growth | 2,761 | 3,141 | 3,838 | 5,144 | 6,203 | 7,798 |
Net Cash Growth | -15.34% | -18.17% | -25.38% | -17.07% | -20.46% | 89.68% |
Net Cash Per Share Net Cash Per Share Growth | 6.62 | 7.54 | 9.31 | 12.47 | 15.12 | 18.94 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 152.53 | -63.21 | 95.72 | 408.77 | 130.88 | 2,476 |
Capital Expenditures CapEx Growth | -508.64 | -505.92 | -529.48 | -1,236 | -1,267 | -383.52 |
Free Cash Flow Free Cash Flow Growth | -356.11 | -569.14 | -433.76 | -827.62 | -1,136 | 2,093 |
Free Cash Flow Growth | - | - | - | - | - | -36.62% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 33.79% | 34.27% | 38.87% | 49.37% | 49.99% | 57.95% |
Operating Margin | -13.49% | -16.05% | -19.05% | 2.60% | 12.83% | 24.83% |
Pretax Margin | -14.15% | -16.26% | -22.92% | 2.66% | 14.27% | 25.80% |
Profit Margin | -14.93% | -16.64% | -23.34% | 2.14% | 11.38% | 21.60% |
FCF Margin | -9.27% | -15.36% | -11.22% | -19.03% | -16.10% | 30.93% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.100 | 1.000 | 0.350 |
Dividend Per Share Growth | -90.00% | 185.71% | 0% |
Dividend Yield | 0.21% | 1.97% | 0.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 211.80 | 26.39 | 24.63 |
Forward PE | - | 25.09 | 25.09 | 25.09 | 25.09 | 35.26 |
P/FCF Ratio | - | - | - | - | - | 17.20 |
PS Ratio | 4.07 | 4.70 | 4.14 | 4.52 | 3.00 | 5.32 |